By Dave Sebastian

 

Eli Lilly & Co. and Amgen Inc. said they are collaborating on making Lilly's potential Covid-19 antibody therapies, in an effort to boost supply if the treatment is approved.

The two companies expect to produce millions of doses next year, said Daniel Skovronsky, Lilly's chief scientific officer and president of Lilly Research Laboratories.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

(END) Dow Jones Newswires

September 17, 2020 06:55 ET (10:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Amgen Charts.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Amgen Charts.